Skip to main content
OpenTrials
Completed

NCT Number: NCT05188937

Validity and Reliability of the Dual-task Questionnaire

It is important to increase the independence of Multiple Sclerosis (MS) patients in activities of daily living. Almost all activities of daily living require managing many activities at the same time. For example, walking or standing while talking on the phone. There is a need for easily applicable, reliable and valid scales to evaluate dual-task performance in MS patients. Therefore, the aim of this study is to establish the Turkish cultural adaptation, validity and reliability of the Dual-Task Questionnaire scale in MS patients. This study included a total of 50 patients with MS [age (18-65) years]. Dual-task Questionnaire (DTQ), Timed Up and Go test (TUG) with dual-task and Nine Hole Peg test (9-HPT) with dual-task were applied to the patients. The second evaluation (retest) was carried out by the same physiotherapist one week following the first evaluation (test) in order to measure test-retest reliability.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Ankara, Turkey (Türkiye)

About this study

This study included patients with MS between 0-5,5 score according to the Extended Disability Status Scale (EDSS). DTQ was used to assess the frequency of difficulties associated with daily tasks involving the dual-task. Additionally TUG with dual-task and 9-HPT with dual-task were applied to the patients. An experienced physiotherapist applied all these tests. In order to measure test-retest reliability, a retest was carried out by the same physiotherapist one week following the first evaluation. The construct validity of DTQ was tested by Pearson's correlation coefficient.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Multiple Sclerosis
  • Must be able to ambulatory status (Expanded Disability Status Scale score ≤ 6 )
  • No relapse in the last 3 mounts

Exclusion criteria

  • Orthopedic problems
  • Visual, perception, and hearing problems

Treatment and study plan

validity and reliability study

Procedure

Validity and reliability assessment of the Dual-task Questionnaire

Primary outcomes

  1. Validity and reliability of Dual-Task Questionnaire in patients with MS

    Time frame: one week

    Validity and reliability

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Validity and Reliability of the Dual-task Questionnaire in Multiple Sclerosis Patients

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Jan 12, 2022
Registry last updated
May 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.